Kapiljeet Dargan - CVR Partners Director
| UAN Stock | USD 81.60 5.83 7.69% |
Insider
Kapiljeet Dargan is Director of CVR Partners LP since 2021.
| Age | 38 |
| Tenure | 3 years |
| Address | 2277 Plaza Drive, Sugar Land, TX, United States, 77479 |
| Phone | 281 207 3200 |
| Web | https://www.cvrpartners.com |
CVR Partners Management Efficiency
The company has Return on Asset of 0.0516 % which means that on every $100 spent on assets, it made $0.0516 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1763 %, implying that it generated $0.1763 on every 100 dollars invested. CVR Partners' management efficiency ratios could be used to measure how well CVR Partners manages its routine affairs as well as how well it operates its assets and liabilities. At this time, CVR Partners' Return On Tangible Assets are very stable compared to the past year. As of the 30th of November 2024, Return On Equity is likely to grow to 0.54, while Return On Capital Employed is likely to drop 0.21. At this time, CVR Partners' Other Current Assets are very stable compared to the past year. As of the 30th of November 2024, Intangible Assets is likely to grow to about 49.5 M, while Total Assets are likely to drop about 905.5 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| M Zirakparvar | American Vanguard | 70 | |
| Marcos Lutz | Corteva | 51 | |
| Mark Thompson | Nutrien | N/A | |
| John Richardson | Intrepid Potash | N/A | |
| Cornel Fuerer | Corteva | 57 | |
| Lori Lancaster | Intrepid Potash | 51 | |
| Candace Laing | Nutrien | N/A | |
| Michael McGrane | CF Industries Holdings | 50 | |
| Karen Totland | FMC Corporation | N/A | |
| Chrisopher Lewis | The Mosaic | 57 | |
| Julie Freigang | CF Industries Holdings | 56 | |
| Edward Stone | Intrepid Potash | 61 | |
| Elad Aharonson | ICL Israel Chemicals | 50 | |
| BS MBA | Corteva | 73 | |
| Linda Dempsey | CF Industries Holdings | 60 | |
| Eli Amon | ICL Israel Chemicals | 54 | |
| Floris Bielders | The Mosaic | N/A | |
| Noralee Bradley | Nutrien | N/A | |
| Kerry Preete | Corteva | 60 | |
| Fred Thun | Nutrien | N/A | |
| Janet Giesselman | Corteva | 66 | |
Management Performance
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0516 |
CVR Partners LP Leadership Team
Elected by the shareholders, the CVR Partners' board of directors comprises two types of representatives: CVR Partners inside directors who are chosen from within the company, and outside directors, selected externally and held independent of CVR. The board's role is to monitor CVR Partners' management team and ensure that shareholders' interests are well served. CVR Partners' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, CVR Partners' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Peter Shea, Independent Director of General Partner | ||
| Janice DeVelasco, Vice President - Environmental, Health, Safety and Security of the General Partner | ||
| Dane Neumann, Chief Financial Officer, Executive Vice President | ||
| Dane CPA, CFO, VP | ||
| Melissa JD, General VP | ||
| David Lamp, Executive Chairman of the Board of the General Partner | ||
| David Willetts, Director of General Partner | ||
| Mark Pytosh, CEO of CVR GP LLC and President of CVR GP LLC, Director of CVR GP LLC and Chairman of Environmental, Health and Safety Committee | ||
| Tracy Jackson, Chief Financial Officer, Executive Vice President, Principal Accounting Officer | ||
| Melissa Buhrig, Executive Vice President General Counsel, Secretary | ||
| Hunter Gary, Director of the General Partner | ||
| Patricia Agnello, Director | ||
| Andrew Langham, Director of the General Partner | ||
| Frank Muller, Independent Director of General Partner | ||
| Donna Ecton, Independent Director of General Partner | ||
| Richard Roberts, Investor Officer | ||
| Matthew Bley, Chief Accounting Officer, Corporate Controller of General Partner | ||
| Jeffrey Conaway, Chief Accounting Officer, Vice President Corporate Controller | ||
| John Walter, Sr. VP of CVR GP LLC, General Counsel of CVR GP LLC and Secretary of CVR GP LLC | ||
| Jonathan Frates, Director of the General Partner | ||
| Kapiljeet Dargan, Director |
CVR Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is CVR Partners a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.0516 | ||||
| Profit Margin | 0.1 % | ||||
| Operating Margin | 0.09 % | ||||
| Current Valuation | 1.3 B | ||||
| Shares Outstanding | 10.57 M | ||||
| Shares Owned By Insiders | 0.35 % | ||||
| Shares Owned By Institutions | 43.40 % | ||||
| Number Of Shares Shorted | 80.62 K | ||||
| Price To Earning | 4.31 X |
Pair Trading with CVR Partners
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CVR Partners position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CVR Partners will appreciate offsetting losses from the drop in the long position's value.Moving against CVR Stock
| 0.57 | BHIL | Benson Hill, Common | PairCorr |
| 0.56 | FMC | FMC Corporation | PairCorr |
| 0.5 | YTEN | Yield10 Bioscience | PairCorr |
| 0.5 | NITO | N2OFF Inc Symbol Change | PairCorr |
| 0.37 | BIOX | Bioceres Crop Solutions | PairCorr |
The ability to find closely correlated positions to CVR Partners could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CVR Partners when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CVR Partners - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CVR Partners LP to buy it.
The correlation of CVR Partners is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CVR Partners moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CVR Partners LP moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CVR Partners can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in CVR Partners LP. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Is Fertilizers & Agricultural Chemicals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CVR Partners. If investors know CVR will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CVR Partners listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4.208 | Dividend Share 6.69 | Earnings Share 4.97 | Revenue Per Share 49.895 | Quarterly Revenue Growth (0.04) |
The market value of CVR Partners LP is measured differently than its book value, which is the value of CVR that is recorded on the company's balance sheet. Investors also form their own opinion of CVR Partners' value that differs from its market value or its book value, called intrinsic value, which is CVR Partners' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CVR Partners' market value can be influenced by many factors that don't directly affect CVR Partners' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CVR Partners' value and its price as these two are different measures arrived at by different means. Investors typically determine if CVR Partners is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CVR Partners' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.